Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography, Three-Dimensional | 79 | 2024 | 516 | 8.890 |
Why?
|
Mitral Valve Insufficiency | 27 | 2022 | 187 | 4.580 |
Why?
|
Echocardiography, Transesophageal | 41 | 2022 | 344 | 3.610 |
Why?
|
Mitral Valve | 32 | 2022 | 247 | 3.340 |
Why?
|
Heart Ventricles | 28 | 2022 | 760 | 2.560 |
Why?
|
Echocardiography | 40 | 2024 | 911 | 2.460 |
Why?
|
Ventricular Dysfunction, Left | 17 | 2022 | 318 | 1.880 |
Why?
|
Heart Valve Diseases | 11 | 2024 | 108 | 1.850 |
Why?
|
Atrial Fibrillation | 9 | 2022 | 280 | 1.740 |
Why?
|
Ventricular Function, Left | 22 | 2024 | 589 | 1.710 |
Why?
|
Tricuspid Valve Insufficiency | 7 | 2021 | 111 | 1.560 |
Why?
|
Image Interpretation, Computer-Assisted | 23 | 2011 | 663 | 1.490 |
Why?
|
Echocardiography, Doppler, Color | 15 | 2011 | 103 | 1.380 |
Why?
|
Atrial Appendage | 4 | 2022 | 26 | 1.200 |
Why?
|
Image Enhancement | 12 | 2019 | 563 | 1.160 |
Why?
|
Contrast Media | 9 | 2019 | 1076 | 1.130 |
Why?
|
Stroke Volume | 17 | 2024 | 452 | 1.020 |
Why?
|
Aortic Valve | 10 | 2015 | 220 | 0.980 |
Why?
|
Fluorocarbons | 4 | 2023 | 72 | 0.950 |
Why?
|
Ventricular Function, Right | 3 | 2021 | 142 | 0.920 |
Why?
|
Heart Valve Prosthesis Implantation | 9 | 2021 | 166 | 0.890 |
Why?
|
Reproducibility of Results | 37 | 2022 | 2699 | 0.880 |
Why?
|
Myocardial Ischemia | 5 | 2022 | 159 | 0.870 |
Why?
|
Mitral Valve Stenosis | 8 | 2022 | 37 | 0.850 |
Why?
|
Coronary Artery Bypass | 3 | 2013 | 228 | 0.830 |
Why?
|
Humans | 144 | 2024 | 86281 | 0.820 |
Why?
|
Diastole | 3 | 2018 | 143 | 0.800 |
Why?
|
Heart Neoplasms | 4 | 2013 | 62 | 0.790 |
Why?
|
Male | 87 | 2024 | 40860 | 0.760 |
Why?
|
Coronary Thrombosis | 1 | 2019 | 14 | 0.710 |
Why?
|
Female | 87 | 2024 | 44405 | 0.710 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2020 | 78 | 0.700 |
Why?
|
Shock, Cardiogenic | 1 | 2020 | 94 | 0.690 |
Why?
|
Middle Aged | 79 | 2021 | 24957 | 0.670 |
Why?
|
Vascular Stiffness | 2 | 2015 | 26 | 0.650 |
Why?
|
Echocardiography, Doppler | 8 | 2013 | 187 | 0.640 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 139 | 0.640 |
Why?
|
Aged | 48 | 2022 | 18353 | 0.630 |
Why?
|
Heart Valve Prosthesis | 7 | 2013 | 93 | 0.630 |
Why?
|
Heart Diseases | 9 | 2018 | 290 | 0.630 |
Why?
|
Heart Atria | 9 | 2020 | 245 | 0.580 |
Why?
|
Cardiac Surgical Procedures | 6 | 2021 | 461 | 0.580 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2012 | 159 | 0.530 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 826 | 0.510 |
Why?
|
Magnetic Resonance Imaging | 12 | 2024 | 3347 | 0.500 |
Why?
|
Heart | 7 | 2024 | 538 | 0.500 |
Why?
|
Retrospective Studies | 18 | 2023 | 8431 | 0.490 |
Why?
|
Heart-Assist Devices | 2 | 2020 | 731 | 0.490 |
Why?
|
Heart Septum | 3 | 2008 | 45 | 0.490 |
Why?
|
Elasticity Imaging Techniques | 2 | 2011 | 59 | 0.480 |
Why?
|
Feasibility Studies | 17 | 2019 | 751 | 0.480 |
Why?
|
Sensitivity and Specificity | 22 | 2016 | 1987 | 0.470 |
Why?
|
Computer Systems | 10 | 2011 | 79 | 0.450 |
Why?
|
Heart Septal Defects, Atrial | 8 | 2022 | 64 | 0.440 |
Why?
|
Tricuspid Valve | 2 | 2020 | 96 | 0.430 |
Why?
|
Observer Variation | 17 | 2018 | 601 | 0.410 |
Why?
|
Image Processing, Computer-Assisted | 15 | 2012 | 1200 | 0.410 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2021 | 134 | 0.400 |
Why?
|
Heart Failure | 6 | 2021 | 1196 | 0.400 |
Why?
|
Tomography, X-Ray Computed | 4 | 2010 | 2594 | 0.370 |
Why?
|
Cardiac Catheterization | 7 | 2022 | 291 | 0.370 |
Why?
|
Adult | 43 | 2024 | 25577 | 0.360 |
Why?
|
Cardiac Output | 2 | 2023 | 156 | 0.350 |
Why?
|
Endocardium | 6 | 2009 | 76 | 0.350 |
Why?
|
Hemodynamics | 8 | 2021 | 710 | 0.340 |
Why?
|
Mitral Valve Prolapse | 4 | 2022 | 22 | 0.340 |
Why?
|
Heart Defects, Congenital | 5 | 2020 | 350 | 0.330 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2013 | 380 | 0.330 |
Why?
|
Stroke | 3 | 2022 | 959 | 0.330 |
Why?
|
Ventricular Function | 2 | 2007 | 53 | 0.320 |
Why?
|
Rheumatic Heart Disease | 4 | 2022 | 29 | 0.310 |
Why?
|
Echocardiography, Stress | 2 | 2006 | 20 | 0.300 |
Why?
|
Inpatients | 2 | 2020 | 295 | 0.300 |
Why?
|
Myxoma | 2 | 2004 | 28 | 0.300 |
Why?
|
Aortic Valve Stenosis | 5 | 2013 | 129 | 0.300 |
Why?
|
Follow-Up Studies | 8 | 2021 | 3616 | 0.290 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 197 | 0.290 |
Why?
|
Liver Neoplasms | 1 | 2013 | 731 | 0.290 |
Why?
|
Predictive Value of Tests | 12 | 2018 | 1671 | 0.280 |
Why?
|
Transducers | 5 | 2008 | 41 | 0.280 |
Why?
|
United States | 13 | 2022 | 6637 | 0.270 |
Why?
|
Treatment Outcome | 16 | 2022 | 7949 | 0.260 |
Why?
|
Aortic Diseases | 3 | 2012 | 99 | 0.260 |
Why?
|
Organ Size | 6 | 2019 | 363 | 0.260 |
Why?
|
Defibrillators, Implantable | 2 | 2017 | 129 | 0.260 |
Why?
|
Aortic Coarctation | 2 | 2015 | 35 | 0.250 |
Why?
|
Child, Preschool | 13 | 2015 | 3608 | 0.250 |
Why?
|
Child | 17 | 2022 | 6913 | 0.240 |
Why?
|
Hemodynamic Monitoring | 1 | 2023 | 8 | 0.240 |
Why?
|
Aged, 80 and over | 18 | 2013 | 6481 | 0.240 |
Why?
|
Severity of Illness Index | 10 | 2021 | 1796 | 0.230 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2015 | 95 | 0.230 |
Why?
|
Case-Control Studies | 8 | 2015 | 1801 | 0.230 |
Why?
|
Angioplasty, Balloon | 1 | 2003 | 95 | 0.230 |
Why?
|
Rheumatic Fever | 1 | 2022 | 12 | 0.230 |
Why?
|
Aorta | 3 | 2013 | 280 | 0.230 |
Why?
|
Linear Models | 6 | 2012 | 419 | 0.220 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 345 | 0.220 |
Why?
|
Hospital Mortality | 3 | 2020 | 347 | 0.220 |
Why?
|
Diagnosis, Differential | 6 | 2019 | 1562 | 0.220 |
Why?
|
Vascular Diseases | 1 | 2022 | 119 | 0.200 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 199 | 0.200 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 85 | 0.200 |
Why?
|
Adolescent | 15 | 2022 | 8968 | 0.200 |
Why?
|
Discrete Subaortic Stenosis | 1 | 2020 | 1 | 0.200 |
Why?
|
Cardiac Output, High | 1 | 2020 | 2 | 0.200 |
Why?
|
Aortic Rupture | 1 | 2001 | 55 | 0.200 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 15 | 0.190 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 245 | 0.190 |
Why?
|
Cardiology | 2 | 2012 | 123 | 0.190 |
Why?
|
Infant | 9 | 2015 | 3036 | 0.180 |
Why?
|
Catheter Ablation | 3 | 2014 | 233 | 0.180 |
Why?
|
Endocarditis | 1 | 2019 | 18 | 0.180 |
Why?
|
Triage | 1 | 2020 | 108 | 0.180 |
Why?
|
Atrial Flutter | 1 | 2019 | 33 | 0.180 |
Why?
|
Imaging, Three-Dimensional | 4 | 2013 | 579 | 0.170 |
Why?
|
Atrial Remodeling | 1 | 2018 | 12 | 0.170 |
Why?
|
Algorithms | 6 | 2016 | 1828 | 0.170 |
Why?
|
Laboratories | 1 | 2018 | 43 | 0.160 |
Why?
|
Space Flight | 3 | 2007 | 6 | 0.150 |
Why?
|
Documentation | 1 | 2018 | 98 | 0.150 |
Why?
|
Time Factors | 8 | 2015 | 5198 | 0.150 |
Why?
|
Models, Cardiovascular | 3 | 2012 | 98 | 0.150 |
Why?
|
Myocardial Contraction | 3 | 2007 | 244 | 0.150 |
Why?
|
Weightlessness Simulation | 2 | 2007 | 2 | 0.150 |
Why?
|
Academic Medical Centers | 1 | 2019 | 377 | 0.150 |
Why?
|
Patient-Specific Modeling | 1 | 2016 | 19 | 0.150 |
Why?
|
Communication | 2 | 2018 | 438 | 0.150 |
Why?
|
Heart Transplantation | 2 | 2015 | 705 | 0.140 |
Why?
|
Hypergravity | 2 | 2007 | 2 | 0.140 |
Why?
|
Societies, Medical | 2 | 2018 | 572 | 0.140 |
Why?
|
Reference Values | 5 | 2012 | 673 | 0.140 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2015 | 1 | 0.140 |
Why?
|
Young Adult | 9 | 2015 | 5961 | 0.140 |
Why?
|
Recovery of Function | 3 | 2015 | 272 | 0.140 |
Why?
|
Catheterization | 2 | 2009 | 232 | 0.130 |
Why?
|
Fee-for-Service Plans | 2 | 2013 | 30 | 0.130 |
Why?
|
Liver | 1 | 2020 | 1229 | 0.130 |
Why?
|
Software | 5 | 2013 | 650 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2015 | 73 | 0.130 |
Why?
|
Mass Screening | 1 | 2019 | 615 | 0.130 |
Why?
|
Ultrasonography | 3 | 2013 | 695 | 0.130 |
Why?
|
Ventricular Remodeling | 1 | 2015 | 96 | 0.130 |
Why?
|
Registries | 2 | 2015 | 702 | 0.130 |
Why?
|
Age Factors | 6 | 2013 | 1842 | 0.130 |
Why?
|
Equipment Design | 4 | 2013 | 405 | 0.120 |
Why?
|
Waiting Lists | 1 | 2015 | 175 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 123 | 0.120 |
Why?
|
Cardiomyopathies | 2 | 2007 | 240 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2014 | 41 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 2 | 2013 | 99 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 1 | 2014 | 41 | 0.120 |
Why?
|
Heart Conduction System | 1 | 2014 | 108 | 0.110 |
Why?
|
Data Display | 2 | 2012 | 24 | 0.110 |
Why?
|
Cardiac Catheters | 1 | 2013 | 9 | 0.110 |
Why?
|
Thrombosis | 3 | 2006 | 296 | 0.110 |
Why?
|
Prospective Studies | 7 | 2023 | 4194 | 0.110 |
Why?
|
Coronary Aneurysm | 1 | 2013 | 16 | 0.110 |
Why?
|
Ultrasonic Therapy | 1 | 2013 | 32 | 0.110 |
Why?
|
Heart Septal Defects, Ventricular | 3 | 2005 | 67 | 0.110 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2013 | 47 | 0.110 |
Why?
|
Anemia, Hemolytic | 2 | 2004 | 19 | 0.110 |
Why?
|
Cardiac Volume | 1 | 2012 | 53 | 0.110 |
Why?
|
Electrocardiography | 4 | 2014 | 478 | 0.110 |
Why?
|
Exercise Test | 3 | 2015 | 164 | 0.110 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2012 | 16 | 0.110 |
Why?
|
Prolapse | 2 | 2022 | 10 | 0.110 |
Why?
|
Medicare | 2 | 2013 | 404 | 0.110 |
Why?
|
Heart Valves | 1 | 2012 | 13 | 0.110 |
Why?
|
Multidetector Computed Tomography | 1 | 2012 | 54 | 0.110 |
Why?
|
Sheep | 2 | 2011 | 238 | 0.110 |
Why?
|
Systole | 3 | 2020 | 129 | 0.100 |
Why?
|
Risk Assessment | 5 | 2016 | 2253 | 0.100 |
Why?
|
Equipment Failure Analysis | 2 | 2008 | 90 | 0.100 |
Why?
|
Preoperative Care | 2 | 2012 | 390 | 0.100 |
Why?
|
Coronary Angiography | 1 | 2013 | 229 | 0.100 |
Why?
|
Europe | 4 | 2015 | 308 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 165 | 0.100 |
Why?
|
Calcinosis | 1 | 2012 | 224 | 0.100 |
Why?
|
Phantoms, Imaging | 2 | 2010 | 426 | 0.090 |
Why?
|
Prostheses and Implants | 2 | 2024 | 121 | 0.090 |
Why?
|
Drug Dosage Calculations | 1 | 2009 | 16 | 0.090 |
Why?
|
Benzenesulfonates | 1 | 2009 | 66 | 0.090 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 66 | 0.090 |
Why?
|
Surgical Wound Dehiscence | 1 | 2009 | 37 | 0.090 |
Why?
|
Pulmonary Veins | 2 | 2008 | 72 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2009 | 105 | 0.090 |
Why?
|
Bundle-Branch Block | 1 | 2009 | 48 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 2 | 2013 | 27 | 0.080 |
Why?
|
Papillary Muscles | 1 | 2008 | 17 | 0.080 |
Why?
|
Drug Discovery | 1 | 2009 | 103 | 0.080 |
Why?
|
Body Surface Area | 1 | 2008 | 36 | 0.080 |
Why?
|
Weightlessness | 2 | 2006 | 2 | 0.080 |
Why?
|
Prosthesis Failure | 2 | 2006 | 111 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2010 | 222 | 0.080 |
Why?
|
Survival Rate | 3 | 2021 | 1856 | 0.080 |
Why?
|
Pyridines | 1 | 2009 | 309 | 0.080 |
Why?
|
Prognosis | 2 | 2020 | 3669 | 0.080 |
Why?
|
Thermodilution | 1 | 2007 | 21 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2008 | 160 | 0.070 |
Why?
|
Sarcoidosis | 1 | 2007 | 71 | 0.070 |
Why?
|
Aging | 1 | 2011 | 689 | 0.070 |
Why?
|
Aortic Stenosis, Subvalvular | 1 | 2005 | 5 | 0.070 |
Why?
|
Bioprosthesis | 1 | 2006 | 36 | 0.070 |
Why?
|
Esophageal Perforation | 1 | 2005 | 17 | 0.070 |
Why?
|
Fibroma | 1 | 2005 | 32 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 589 | 0.070 |
Why?
|
Wounds, Stab | 1 | 2005 | 9 | 0.070 |
Why?
|
Prevalence | 2 | 2022 | 1239 | 0.060 |
Why?
|
Heart Rate | 2 | 2007 | 492 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 347 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 306 | 0.060 |
Why?
|
Gravitation | 1 | 2004 | 5 | 0.060 |
Why?
|
Myocardium | 2 | 2006 | 528 | 0.060 |
Why?
|
Ultrasonography, Interventional | 3 | 2013 | 121 | 0.060 |
Why?
|
Endocarditis, Bacterial | 1 | 2004 | 33 | 0.060 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2004 | 87 | 0.060 |
Why?
|
Streptococcal Infections | 1 | 2004 | 57 | 0.060 |
Why?
|
Decision Making | 1 | 2010 | 641 | 0.060 |
Why?
|
Finite Element Analysis | 2 | 2016 | 74 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 739 | 0.060 |
Why?
|
Risk Factors | 4 | 2021 | 5397 | 0.060 |
Why?
|
Patient Selection | 3 | 2009 | 685 | 0.060 |
Why?
|
Animals | 5 | 2011 | 26518 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 468 | 0.060 |
Why?
|
Back Pain | 1 | 2023 | 42 | 0.060 |
Why?
|
Heart Septal Defects | 1 | 2003 | 31 | 0.060 |
Why?
|
Vascular Resistance | 1 | 2023 | 99 | 0.060 |
Why?
|
Acoustics | 1 | 2003 | 51 | 0.060 |
Why?
|
Headache | 1 | 2023 | 73 | 0.060 |
Why?
|
Marketing of Health Services | 1 | 2002 | 15 | 0.060 |
Why?
|
Incidence | 2 | 2023 | 1568 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 1030 | 0.060 |
Why?
|
Cohort Studies | 3 | 2016 | 2759 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2024 | 318 | 0.050 |
Why?
|
Anticoagulants | 2 | 2022 | 404 | 0.050 |
Why?
|
Aortic Valve Insufficiency | 2 | 2001 | 129 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2005 | 238 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2023 | 268 | 0.050 |
Why?
|
Prosthesis Design | 2 | 2015 | 277 | 0.050 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 49 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2002 | 107 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 21 | 0.050 |
Why?
|
Connecticut | 1 | 2021 | 27 | 0.050 |
Why?
|
ROC Curve | 3 | 2010 | 752 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2021 | 57 | 0.050 |
Why?
|
Swine | 3 | 1997 | 554 | 0.050 |
Why?
|
Activin Receptors, Type II | 1 | 2020 | 9 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 307 | 0.050 |
Why?
|
Aftercare | 1 | 2022 | 84 | 0.050 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 362 | 0.050 |
Why?
|
Vascular Malformations | 1 | 2020 | 19 | 0.050 |
Why?
|
Artificial Intelligence | 1 | 2003 | 294 | 0.050 |
Why?
|
Data Collection | 1 | 2022 | 371 | 0.050 |
Why?
|
Illinois | 3 | 2008 | 461 | 0.050 |
Why?
|
Dobutamine | 3 | 2006 | 61 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 200 | 0.050 |
Why?
|
Patient Readmission | 2 | 2013 | 324 | 0.040 |
Why?
|
Patient Discharge | 1 | 2022 | 296 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2011 | 912 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2022 | 1015 | 0.040 |
Why?
|
Gadolinium | 1 | 2018 | 103 | 0.040 |
Why?
|
Disease Progression | 1 | 2022 | 1531 | 0.040 |
Why?
|
Fibrosis | 1 | 2018 | 202 | 0.040 |
Why?
|
Motion | 2 | 2010 | 85 | 0.040 |
Why?
|
Lower Body Negative Pressure | 2 | 2007 | 3 | 0.040 |
Why?
|
Rotation | 1 | 1997 | 89 | 0.040 |
Why?
|
Sex Factors | 2 | 2011 | 1053 | 0.040 |
Why?
|
Survival Analysis | 1 | 2020 | 1536 | 0.040 |
Why?
|
Comorbidity | 1 | 2020 | 943 | 0.040 |
Why?
|
Pregnancy | 1 | 2023 | 2885 | 0.040 |
Why?
|
Automation | 1 | 2016 | 106 | 0.040 |
Why?
|
Holography | 1 | 1995 | 4 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2015 | 48 | 0.030 |
Why?
|
Artifacts | 2 | 2009 | 244 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2010 | 2369 | 0.030 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2014 | 21 | 0.030 |
Why?
|
Formates | 1 | 2014 | 6 | 0.030 |
Why?
|
Movement | 2 | 2006 | 299 | 0.030 |
Why?
|
Triazines | 1 | 2014 | 47 | 0.030 |
Why?
|
Patient Safety | 1 | 2016 | 212 | 0.030 |
Why?
|
Bioengineering | 1 | 2013 | 12 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 2 | 2006 | 261 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 859 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2013 | 71 | 0.030 |
Why?
|
Hypertension | 1 | 2001 | 1139 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2013 | 116 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2013 | 121 | 0.030 |
Why?
|
Research | 1 | 2013 | 253 | 0.030 |
Why?
|
Coronary Circulation | 2 | 2004 | 127 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2011 | 90 | 0.020 |
Why?
|
Postoperative Care | 1 | 2012 | 220 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2013 | 220 | 0.020 |
Why?
|
Aortography | 1 | 2010 | 63 | 0.020 |
Why?
|
Length of Stay | 1 | 2013 | 697 | 0.020 |
Why?
|
Preoperative Period | 1 | 2010 | 91 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 677 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2000 | 2183 | 0.020 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 115 | 0.020 |
Why?
|
Niacinamide | 1 | 2009 | 116 | 0.020 |
Why?
|
Exanthema | 1 | 2009 | 36 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 303 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2009 | 113 | 0.020 |
Why?
|
Mutation | 1 | 2020 | 3952 | 0.020 |
Why?
|
Electric Countershock | 1 | 2009 | 47 | 0.020 |
Why?
|
Age Distribution | 1 | 2009 | 204 | 0.020 |
Why?
|
Queensland | 1 | 2008 | 5 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2009 | 119 | 0.020 |
Why?
|
Diarrhea | 1 | 2009 | 181 | 0.020 |
Why?
|
Treatment Failure | 1 | 2009 | 284 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 1610 | 0.020 |
Why?
|
Quality Improvement | 1 | 2012 | 423 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2009 | 987 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2012 | 369 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2008 | 237 | 0.020 |
Why?
|
Perinatology | 1 | 2006 | 14 | 0.020 |
Why?
|
Electrophysiology | 1 | 2007 | 401 | 0.020 |
Why?
|
Radiography | 1 | 2009 | 812 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2008 | 174 | 0.020 |
Why?
|
Weightlessness Countermeasures | 1 | 2006 | 1 | 0.020 |
Why?
|
Hospitalization | 1 | 2012 | 844 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2007 | 248 | 0.020 |
Why?
|
Thoracic Wall | 1 | 2006 | 21 | 0.020 |
Why?
|
Pilot Projects | 1 | 2008 | 837 | 0.020 |
Why?
|
Microcirculation | 1 | 2006 | 103 | 0.020 |
Why?
|
Reference Standards | 1 | 2006 | 159 | 0.020 |
Why?
|
Color | 1 | 2006 | 81 | 0.020 |
Why?
|
Ultrasonography, Prenatal | 1 | 2006 | 152 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2006 | 87 | 0.020 |
Why?
|
Patient Care Team | 1 | 2008 | 280 | 0.020 |
Why?
|
Syndrome | 1 | 2006 | 446 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 120 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 429 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2006 | 152 | 0.020 |
Why?
|
Aerospace Medicine | 1 | 2004 | 14 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2006 | 185 | 0.020 |
Why?
|
Spain | 1 | 2004 | 33 | 0.020 |
Why?
|
Anthropometry | 1 | 2004 | 74 | 0.020 |
Why?
|
Chronic Disease | 1 | 2008 | 968 | 0.020 |
Why?
|
Myocardial Reperfusion | 1 | 2004 | 27 | 0.020 |
Why?
|
Posture | 1 | 2004 | 125 | 0.020 |
Why?
|
Research Design | 1 | 2007 | 594 | 0.010 |
Why?
|
Coronary Disease | 1 | 2004 | 261 | 0.010 |
Why?
|
Palliative Care | 1 | 2004 | 256 | 0.010 |
Why?
|
Reoperation | 1 | 2005 | 589 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2004 | 372 | 0.010 |
Why?
|
Heart Aneurysm | 1 | 1999 | 22 | 0.010 |
Why?
|
Thorax | 1 | 1999 | 75 | 0.010 |
Why?
|
Aneurysm, False | 1 | 1999 | 54 | 0.010 |
Why?
|
Albumins | 1 | 1999 | 133 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1995 | 197 | 0.010 |
Why?
|
Vena Cava, Superior | 1 | 1995 | 59 | 0.010 |
Why?
|
Cattle | 1 | 1995 | 374 | 0.010 |
Why?
|
Video Recording | 1 | 1995 | 190 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1995 | 201 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1995 | 305 | 0.010 |
Why?
|
Forecasting | 1 | 1994 | 303 | 0.010 |
Why?
|
Terminology as Topic | 1 | 1994 | 217 | 0.010 |
Why?
|